Health
US Sees New Home-Based STD Tests and Treatments Amid Falling Infection Rates
Last year, US authorities approved the first at-home test capable of detecting three common infections in women — gonorrhea, chlamydia, and trichomoniasis — as well as the first home-based kit for the virus that causes cervical cancer. Experts say these new options for testing and treatment could help reduce infection rates nationwide.
The Food and Drug Administration (FDA) also approved two new drugs for gonorrhea in 2025, marking the first new treatment options for the disease in decades. Gonorrhea has been increasingly resistant to antibiotics, and the new oral medications provide an alternative to the standard injectable treatment. Nuzolvenc, developed through a public-private partnership, comes in granules that dissolve in water, while Bluejepa, produced by GlaxoSmithKline, is a tablet also approved for urinary tract infections.
“Sexual health can be stigmatised, and people can be hesitant about testing,” said Dr. Ina Park, a sexual health specialist at the University of California. “Now we have a lot of options for patients who may be wary of going into a provider’s office.”
The new home-based tests aim to make testing more convenient and faster. Visby Medical launched its three-in-one test for women following FDA approval in March 2025. The urine-based kit includes a vaginal swab and a small electronic device that processes the results and sends them to an online app. A telehealth consultation with a medical provider is included, allowing patients to discuss results and receive prescriptions within hours. The entire process can take as little as six hours, compared with several days under traditional lab-based testing, said Dr. Gary Schoolnik, Visby’s chief medical officer.
In May, the FDA approved Teal Health’s home-based HPV test. The Teal Wand allows women to collect samples at home and ship them to a laboratory for processing. Updated federal guidelines now endorse self-collection for HPV screening for the first time.
Provisional CDC data for 2024 showed a third consecutive year of declining gonorrhea cases, along with decreases in adult chlamydia and infectious syphilis. Experts attribute the trend to a combination of factors, including changes in sexual activity, increased use of preventative antibiotics, and the rise of at-home testing.
Some experts, however, caution that home testing could make national infection tracking more challenging. High costs may also limit access: Visby’s test costs $150 and is not covered by most insurance. Public health funding cuts may further restrict access to testing and treatment for underserved populations.
“I’m optimistic that more testing options and new drugs will help reduce infection rates,” Dr. Park said. “The risk is that cuts to public health could prevent the people who need these tools most from accessing them.”
The new approvals mark a shift toward patient-centered sexual health care, combining convenience, speed, and broader access to treatment options, even as challenges remain in ensuring equitable availability.
Health
Global Mental Health Cases Near 1.2 Billion as Anxiety and Depression Drive Sharp Worldwide Rise
A major global analysis has found that mental health conditions have surged to an estimated 1.2 billion people worldwide, driven largely by steep increases in anxiety and depression over the past three decades.
The findings, published in The Lancet as part of the Global Burden of Disease Study 2023, show that the number of people living with mental disorders has almost doubled since 1990, marking a 95% rise. Researchers say major depressive disorder and anxiety disorders have seen even sharper growth, increasing by 131% and 158% respectively, making them the most prevalent mental health conditions globally.
The report describes mental illnesses as widespread conditions that create long-term disability and significant human suffering. It also highlights broader consequences for economies and public services, including reduced productivity, lower workforce participation and increasing pressure on health and welfare systems.
Researchers estimate that in 2023 alone, around 620 million females and 552 million males were affected by mental health conditions. While the overall burden is rising across both sexes, the study points to notable differences in the types and prevalence of disorders.
Among women, depression and anxiety were the most commonly reported conditions, alongside higher rates of eating disorders such as anorexia nervosa and bulimia nervosa. The report links this disparity to a mix of biological, social and structural factors, including exposure to domestic violence, sexual abuse, gender inequality and reproductive health-related changes.
In contrast, neurodevelopmental and behavioural disorders, including attention deficit hyperactivity disorder (ADHD), conduct disorder and autism spectrum conditions, were more frequently diagnosed in men.
Teenagers aged 15 to 19 were identified as the group experiencing the highest mental health burden globally, raising concerns about early onset of conditions and insufficient preventive care for young people.
The study identifies several key risk factors associated with mental illness, including childhood sexual violence, bullying and intimate partner violence. These factors are strongly linked to conditions such as depression, schizophrenia, bipolar disorder and anxiety disorders. However, researchers note that such exposures have remained relatively stable over time and account for only a portion of the overall rise.
According to the authors, broader drivers are likely contributing to the increasing prevalence of mental disorders. These include genetic and biological influences, poverty, inequality, and the growing impact of global crises such as armed conflict, pandemics, natural disasters and climate-related stress.
While mental health conditions have long been a leading cause of disability worldwide, the report warns that the situation is worsening. At the same time, health systems have not expanded services at a pace matching demand.
The authors caution that the gap between rising need and limited access to care is becoming more pronounced, leaving millions without adequate treatment or support.
Health
Europe Records Sharp Rise in Sexually Transmitted Infections, ECDC Warns
Health
White House Rejects Report It Blocked Return of Ebola-Infected US Doctor
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
